The present review aims to summarize the role of galectin-3 in non-cirrhotic cardiac diseases and cirrhotic cardiomyopathy and to explore whether it may be a therapeutic target in cirrhotic cardiomyopathy. Here, LGALS3 is linked to heart disorder.